VIR-576
Jump to navigation
Jump to search
VIR-576
VIR-576 (/vɪər-576/) is an experimental antiviral drug that was developed for the treatment of HIV infection.
Etymology
The name "VIR-576" is derived from the prefix "VIR", which is an abbreviation for "virus", and "576", which is a numerical identifier. The name signifies the drug's purpose, which is to combat viral infections, specifically HIV.
Pronunciation
The pronunciation of VIR-576 is "veer-five-seven-six".
Related Terms
- Antiviral drug: A type of medication used specifically for treating viral infections.
- HIV: Human Immunodeficiency Virus, a virus that attacks the body's immune system.
- AIDS: Acquired Immunodeficiency Syndrome, a chronic, potentially life-threatening condition caused by HIV.
- Protease inhibitor: A type of antiviral drug that prevents viral replication by selectively binding to viral proteases.
- Reverse transcriptase inhibitor: A type of antiviral drug that inhibits the action of reverse transcriptase, a viral DNA polymerase that is required for replication of HIV.
See Also
External links
- Medical encyclopedia article on VIR-576
- Wikipedia's article - VIR-576
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski